European biotechs should leverage its innovation and collaborate with Asian manufacturing hubs to secure greater investment, ...

Despite ADX-629 meeting all its endpoints in a Phase II trial, Aldeyra is culling the asset as part of a pipeline ...

GSK now owns the global development and commercialisation rights to Empirico's COPD-targeting (siRNA) oligonucleotide, ...

Leading clinicians, researchers & pharmaceutical innovators gathered to discuss the future of cancer treatment.

Lifecore Biomedical and PolyPeptide Laboratories have linked to deliver an end-to-end peptide manufacturing solution for US ...

In the complex and challenging field of early-phase clinical trials, logistics specialists are vital. A recent podcast spoke ...

The foremost geopolitical rivalry between the US and China is increasingly being played out through trade and economic ...

The company points to “emerging research” that shows GLP-1RA medications offer benefits beyond weight loss for patients ...

Regeneron is planning to re-apply to the FDA with a new pre-filled syringe manufacturing filler in January 2026.

MHLW of Japan has granted orphan regenerative medicine product designation to Kyowa Kirin and Orchard Therapeutics’ MLD therapy..

An increasing demand for gene therapies is focusing the industry on enhancing production capabilities, transitioning from ...

Norway's completed health tech assessments in 2025 were evaluated as positive, and raising thresholds may improve access conditions.